The Procter & Gamble Company Other Comprehensive Income (Loss), Derivative, Excluded Component, Increase (Decrease), before Adjustments and Tax
The Procter & Gamble Company (PG) reported Other Comprehensive Income (Loss), Derivative, Excluded Component, Increase (Decrease), before Adjustments and Tax of $242.00 million for the 12-month period ending 2026-06-30, per its 10-K filed 2026-08-04.
Financial Statements › Income Statement › Unrealized Gains
us-gaap:OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseBeforeAdjustmentsAndTax · last filed 2026-08-04
- The Procter & Gamble Company other comprehensive income (loss), derivative, excluded component, increase (decrease), before adjustments and tax for the quarter ending 2026-06-30 was $51.00M, a 13.56% decline year-over-year.
- The Procter & Gamble Company other comprehensive income (loss), derivative, excluded component, increase (decrease), before adjustments and tax for the quarter ending 2026-03-31 was $56.00M, a 6.67% decline year-over-year.
- The Procter & Gamble Company other comprehensive income (loss), derivative, excluded component, increase (decrease), before adjustments and tax for the quarter ending 2025-12-31 was $65.00M, a 14.04% increase year-over-year.
- The Procter & Gamble Company other comprehensive income (loss), derivative, excluded component, increase (decrease), before adjustments and tax for the quarter ending 2025-09-30 was $71.00M, a 42.00% increase year-over-year.
- The Procter & Gamble Company other comprehensive income (loss), derivative, excluded component, increase (decrease), before adjustments and tax for fiscal 2026 was $242.00M, a 7.08% increase from fiscal 2025.
- The Procter & Gamble Company other comprehensive income (loss), derivative, excluded component, increase (decrease), before adjustments and tax for fiscal 2025 was $226.00M, a 1.31% decline from fiscal 2024.
- The Procter & Gamble Company other comprehensive income (loss), derivative, excluded component, increase (decrease), before adjustments and tax for fiscal 2024 was $229.00M, a 3.78% decline from fiscal 2023.
- The Procter & Gamble Company other comprehensive income (loss), derivative, excluded component, increase (decrease), before adjustments and tax for fiscal 2023 was $238.00M.
| Period end | Other Comprehensive Income (Loss), Derivative, Excluded Component, Increase (Decrease), before Adjustments and Tax 3 month | Other Comprehensive Income (Loss), Derivative, Excluded Component, Increase (Decrease), before Adjustments and Tax 6 month | Other Comprehensive Income (Loss), Derivative, Excluded Component, Increase (Decrease), before Adjustments and Tax 9 month | Other Comprehensive Income (Loss), Derivative, Excluded Component, Increase (Decrease), before Adjustments and Tax 12 month |
|---|---|---|---|---|
| 2026-06-30 | $51.00M derived: 10-K 12 month − 10-Q 9 month · filed 2026-08-04 | $107.00M derived: sum of 2 quarters · filed 2026-08-04 | $172.00M derived: sum of 3 quarters · filed 2026-08-04 | $242.00M 10-K · filed 2026-08-04 |
| 2026-03-31 | $56.00M 10-Q · filed 2026-04-24 | $121.00M derived: sum of 2 quarters · filed 2026-04-24 | $191.00M 10-Q · filed 2026-04-24 | $251.00M derived: sum of 4 quarters · filed 2026-08-04 |
| 2025-12-31 | $65.00M 10-Q · filed 2026-01-23 | $136.00M 10-Q · filed 2026-01-23 | $195.00M derived: sum of 3 quarters · filed 2026-08-04 | $255.00M derived: sum of 4 quarters · filed 2026-08-04 |
| 2025-09-30 | $71.00M 10-Q · filed 2025-10-24 | $130.00M derived: sum of 2 quarters · filed 2026-08-04 | $190.00M derived: sum of 3 quarters · filed 2026-08-04 | $247.00M derived: sum of 4 quarters · filed 2026-08-04 |
| 2025-06-30 | $59.00M derived: 10-K 12 month − 10-Q 9 month · filed 2026-08-04 | $119.00M derived: sum of 2 quarters · filed 2026-08-04 | $176.00M derived: sum of 3 quarters · filed 2026-08-04 | $226.00M 10-K · filed 2026-08-04 |
| 2025-03-31 | $60.00M 10-Q · filed 2026-04-24 | $117.00M derived: sum of 2 quarters · filed 2026-04-24 | $167.00M 10-Q · filed 2026-04-24 | $214.00M derived: sum of 4 quarters · filed 2026-08-04 |
| 2024-12-31 | $57.00M 10-Q · filed 2026-01-23 | $107.00M 10-Q · filed 2026-01-23 | $154.00M derived: sum of 3 quarters · filed 2026-08-04 | $207.00M derived: sum of 4 quarters · filed 2026-08-04 |
| 2024-09-30 | $50.00M 10-Q · filed 2025-10-24 | $97.00M derived: sum of 2 quarters · filed 2026-08-04 | $150.00M derived: sum of 3 quarters · filed 2026-08-04 | $212.00M derived: sum of 4 quarters · filed 2026-08-04 |
| 2024-06-30 | $47.00M derived: 10-K 12 month − 10-Q 9 month · filed 2026-08-04 | $100.00M derived: sum of 2 quarters · filed 2026-08-04 | $162.00M derived: sum of 3 quarters · filed 2026-08-04 | $229.00M 10-K · filed 2026-08-04 |
| 2024-03-31 | $53.00M 10-Q · filed 2025-04-24 | $115.00M derived: sum of 2 quarters · filed 2025-04-24 | $182.00M 10-Q · filed 2025-04-24 | |
| 2023-12-31 | $62.00M 10-Q · filed 2025-01-22 | $130.00M 10-Q · filed 2025-01-22 | ||
| 2023-09-30 | $67.00M 10-Q · filed 2024-10-18 | |||
| 2023-06-30 | $238.00M 10-K · filed 2024-08-05 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ECOLAB INC. (ECL) | United States | $77.183B | 36.58 |
| CHURCH & DWIGHT CO INC /DE/ (CHD) | United States | $22.622B | 30.81 |
| STEPAN CO (SCL) | United States | $1.451B | -477.05 |
| Longevity Health Holdings, Inc. (XAGE) | United States | $0.006B | -0.09 |